Raymond James Financial Services Advisors’s Strata Critical Medical Inc SRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding SRTA
AIM
HVCM
NAMA
EMG
Raymond James Financial Services Advisors's SRTA Position: Q2 2022 in Review
Raymond James Financial Services Advisors sold out of Strata Critical Medical Inc (SRTA) in Q2 2022, closing a stake of 11,754 shares — an estimated $100K sold.
Raymond James Financial Services Advisors first reported a position in SRTA in Q3 2021 and held it in 3 quarters. The position peaked at $209K in Q3 2021. 96 funds tracked by Wall St. Rank hold SRTA as of Q2 2022.
- Raymond James Financial Services Advisors reported no remaining Strata Critical Medical Inc position as of Q2 2022 after selling out during the quarter.
- Raymond James Financial Services Advisors sold 11,754 Strata Critical Medical Inc shares in Q2 2022, an estimated $100K.
- Raymond James Financial Services Advisors first reported a position in Strata Critical Medical Inc in Q3 2021 and held it in 3 quarters.
- Raymond James Financial Services Advisors's Strata Critical Medical Inc position peaked at $209K in Q3 2021.
- 96 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2022.
Based on Raymond James Financial Services Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.